➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Harvard Business School
Boehringer Ingelheim
Express Scripts
Mallinckrodt

Last Updated: December 5, 2020

DrugPatentWatch Database Preview

Litigation Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-07-06
Court District Court, D. New Jersey Date Terminated
Cause 15:1126 Patent Infringement Assigned To Claire Claudia Cecchi
Jury Demand Plaintiff Referred To Mark Falk
Parties HUAHAI US INC.; PRINSTON PHARMACEUTICAL, INC.; SEBELA INTERNATIONAL LIMITED; SEBELA IRELAND LIMITED; SEBELA PHARMACEUTICALS INC.; SOLCO HEALTHCARE U.S., LLC
Patents 6,063,927; 6,080,759; 6,113,944; 6,172,233; 7,598,271; 8,658,663; 8,946,251; 9,393,237
Attorneys JAYITA GUHANIYOGI
Link to Docket External link to docket
Small Molecule Drugs cited in SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-07-10 11 HOLDER or l'ATENT OR TRADEMARK. I us 9,393,237 7/19/2016 … ~ 0 Trademarks or ~Patents. ( O the patent action involves 35 U.S.C. § 292.): DOCKET… AO120 Patent Form filed. (jr) (Entered: 07/10/2017) 10 July 2017 PACER Document … REPORT ON THE Director of the U.S. Patent and Trademark Office … ACTION REGARDING A PATENT OR Alexandria, VA 22313 External link to document
2017-07-20 22 paroxetine derivatives are is disclosed in US 6,063,927. US 6,440,459 and US 2004/0143120 disclose paroxetine…ANDERSEN ET AL. !S.K./ A15 US-6,063 927 5/16/2000 …issue date of the patent, and will include the patent term adjustment on the patent. Any request for reconsideration…infringes Plaintiff’s U.S. Patent Nos. 5,874,447 (“’447 patent”); 7,598,271 (“’271 patent”); 8,658,663…,663 (“’663 patent”); and 8,946,251 (“’251 patent”) (collectively “patents-in-suit”) under 35 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKesson
Merck
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.